Periampullary lesions
The periampullary region is the small area where the bile duct and pancreatic duct converge and enter the duodenum through the ampulla of Vater. Four different structures meet within a couple of centimetres, and a tumour can arise from any of them. They present almost identically — usually with painless jaundice — and are frequently removed by the same operation. But they are different diseases with markedly different outlooks, and separating them matters.
How they form
Four origins are recognised, and the distinction is made on the tissue of origin rather than on where the tumour appears to sit:
- Ampullary carcinoma — arising from the ampulla itself. Often develops from a benign ampullary adenoma through an adenoma-to-carcinoma sequence comparable to that in the colon.
- Distal cholangiocarcinoma — from the lower end of the bile duct.
- Duodenal adenocarcinoma — from the duodenal lining around the ampulla.
- Pancreatic ductal adenocarcinoma of the head — the commonest of the four and the one with the poorest outlook.
Because the ampulla sits at a narrow outlet through which bile must pass, even a small tumour here obstructs the bile duct early. That is why periampullary tumours — ampullary ones especially — tend to be found at a smaller size and earlier stage than pancreatic tumours elsewhere in the gland, and why their prognosis is correspondingly better.
Ampullary adenomas may occur sporadically or as part of familial adenomatous polyposis, in which duodenal and ampullary adenomas are common and require surveillance. Any patient with an ampullary adenoma should have their colon examined and a family history taken.
Symptoms
- Painless obstructive jaundice — the classic presentation. Dark urine, pale stools, itching.
- Fluctuating jaundice, which is more characteristic of ampullary tumours, as necrotic tumour sloughs and temporarily relieves the obstruction. This fluctuation can be falsely reassuring.
- Anaemia or occult gastrointestinal bleeding, from an ulcerated ampullary or duodenal tumour.
- Weight loss, anorexia, steatorrhoea.
- Episodes of pancreatitis, where the pancreatic duct is obstructed.
- Vomiting, if the duodenum is obstructed.
How the diagnosis is made
Pancreatic protocol CT defines the lesion, the level of obstruction, and the relationship to the major vessels. MRI with MRCP demonstrates the ducts — the classic "double duct sign", where both bile and pancreatic ducts are dilated, indicates obstruction at the level of the ampulla.
Side-viewing endoscopy is essential and is often omitted. A standard forward-viewing gastroscope looks past the ampulla; a duodenoscope looks directly at it, allowing the lesion to be seen and biopsied. Endoscopic ultrasound then assesses depth of invasion and local nodes, which determines whether local excision is feasible.
ERCP permits biopsy and biliary stenting where drainage is needed. Stenting before surgery is not routine — it is reserved for patients with cholangitis, severe symptoms, or those in whom surgery will be delayed, since routine preoperative stenting increases infective complications.
A practical caution: biopsies taken from the surface of an ampullary lesion frequently show adenoma when invasive carcinoma is present deeper within. A benign biopsy does not exclude cancer, and management should not rest on it alone.
Treatment
Endoscopic papillectomy
For benign ampullary adenomas without invasion and without extension into the ducts, endoscopic removal is appropriate and avoids major surgery. It requires careful selection on endoscopic ultrasound, and careful follow-up, since recurrence is recognised.
Surgical ampullectomy
Local surgical excision of the ampulla with reimplantation of the ducts. Used in selected benign lesions not amenable to endoscopic removal. It is not an adequate cancer operation, because it does not address lymph nodes.
Pancreaticoduodenectomy
The standard operation for periampullary malignancy, removing the head of the pancreas, duodenum, gallbladder, distal bile duct and regional lymph nodes, with reconstruction. It is the same operation regardless of which of the four tissues the tumour arose from, which is why the definitive distinction is often made only on the final pathology.
Chemotherapy
Adjuvant treatment is given according to the final histology, and here the distinction between the four types genuinely changes the regimen. This is the practical reason that identifying the tissue of origin is not merely academic.
Prognosis — why the distinction matters
Presented with identical symptoms and the same operation, the four tumours carry substantially different outlooks. Ampullary and duodenal carcinomas have the best prognosis, distal cholangiocarcinoma is intermediate, and pancreatic ductal adenocarcinoma the poorest. Ampullary tumours are further subdivided by histological subtype — intestinal-type behaves better than pancreatobiliary-type — and this influences adjuvant treatment.
Patients are frequently told they have "pancreatic cancer" when the tumour is in fact ampullary, and are given a prognosis that does not apply to them. Correcting that is one of the more valuable things a specialist assessment provides.
Recovery
After pancreaticoduodenectomy, typically eight to fourteen days in hospital and two to three months to full recovery, with the specific complications of pancreatic fistula, delayed gastric emptying and bleeding. After endoscopic papillectomy, recovery is far quicker, though pancreatitis and bleeding are recognised risks and a temporary pancreatic duct stent is often placed.
Follow-up
After resection for malignancy, clinical review, tumour markers and imaging at regular intervals. After endoscopic or local excision of an adenoma, endoscopic surveillance is required, as recurrence is common. Patients with familial adenomatous polyposis need lifelong duodenal surveillance.
When to seek a specialist opinion
Painless jaundice requires urgent investigation in every case. Two specific points are worth pressing: ask whether the ampulla has actually been examined with a side-viewing endoscope, since it is otherwise easily missed; and ask which of the four periampullary tumours is thought to be present, because a prognosis quoted for pancreatic cancer may not be the right one for that patient.
Common questions
What does "periampullary" mean?
It refers to the small area where the bile duct and the pancreatic duct join and open into the duodenum. Four different cancers arise within a centimetre or two of each other there — from the ampulla itself, the lower bile duct, the duodenal lining and the head of the pancreas. They look similar on scans and cause the same symptoms, but they behave quite differently.
Why does it matter which one I have?
Because the outlook differs substantially. Tumours of the ampulla and duodenum generally have a considerably better prognosis than those arising from the pancreas, even when the operation performed is identical. Knowing the origin gives you a far more accurate picture of what to expect and guides the chemotherapy afterwards.
Why did I turn yellow without any pain?
Because a tumour at this site blocks the bile duct gradually. Stones cause pain because they obstruct suddenly and intermittently; a tumour does not. Painless jaundice with dark urine and pale stools is the classic presentation and should always be investigated promptly.
Why was my stool pale and my urine dark?
Because bile, which gives stool its colour, cannot reach the intestine, so stool becomes pale. The bile pigment instead accumulates in the blood and is excreted by the kidneys, darkening the urine. Together with yellow eyes and itching, this is the picture of a blocked bile duct.
Can a small tumour be removed through an endoscope?
Sometimes. A benign adenoma of the ampulla, and occasionally a very early cancer confined to it, can be removed endoscopically, avoiding a major operation. This requires careful assessment beforehand with ultrasound through the endoscope to confirm the tumour has not invaded deeper, and it is not suitable where it extends into the ducts.
Why do I need such a big operation for a small tumour?
Because the bile duct, the pancreatic duct and the duodenum share a blood supply and converge at this point, so removing the tumour with an adequate margin means removing all of them together. This is the Whipple operation, and it is the standard treatment for invasive tumours here.
Should a stent be placed before surgery?
Not always. Draining the bile duct before an operation was once routine but is now known to increase the risk of infection afterwards. Where surgery can be done reasonably promptly, going straight to the operation is often preferable. A stent is used where surgery must be delayed, where chemotherapy is being given first, or where jaundice is severe with complications.
Will I need chemotherapy afterwards?
It depends on the origin of the tumour and its stage, which is one more reason the precise diagnosis matters. Chemotherapy after surgery is standard for pancreatic and bile duct origin; for ampullary and duodenal tumours the decision depends on the microscopic subtype and the stage.
Related conditions
Other conditions of the pancreas covered on this site:
- Pancreatic ductal adenocarcinoma
- Acute pancreatitis
- Chronic pancreatitis and its complications
- Pancreatic cysts — IPMN and MCN
- Pancreatic neuroendocrine tumours
- Solid pseudopapillary neoplasm and other rare pancreatic tumours
- Pancreas divisum
- Annular pancreas
This page provides general information and does not replace an individual medical consultation. Assessment and treatment are decided for each patient after review of their history, examination and imaging, and in the setting of a multidisciplinary team.